Helen Wohlberg & Herman Lambert Chair in Pharmacokinetics, Divisions of Pediatric Clinical Pharmacology and Allergy and Immunology, Department of Pediatrics, National Jewish Health, University of Colorado School of Medicine, Denver, CO 80206, USA.
Curr Opin Immunol. 2011 Dec;23(6):801-7. doi: 10.1016/j.coi.2011.07.014. Epub 2011 Aug 11.
Although national asthma guidelines help organize standards for asthma care, current asthma management is still primarily symptom based. Recent reports provide insights on how to improve asthma management through steps to better understand the natural history of asthma, individualize asthma care, reduce asthma exacerbations, manage inner city asthma, and some potential new ways to use available medications to improve asthma control. Despite many significant gains in managing asthma, we must now find improved strategies to prevent asthma exacerbations, alter the natural history of the disease, and to reduce health disparities in asthma care. Perhaps new directions in personalized medicine including a systems biology approach, along with improved health care access and communication will lead to better methods to alleviate the burden of asthma. This review will discuss the benefits and limitations of the current approach to asthma management, new studies that could impact new directions in asthma management, and new insights related to mechanisms of asthma and allergic airways inflammation that could eventually lead to improved asthma control.
尽管国家哮喘指南有助于为哮喘护理制定标准,但目前的哮喘管理仍然主要基于症状。最近的报告提供了一些见解,介绍了如何通过以下步骤来改善哮喘管理:更好地了解哮喘的自然史、个体化哮喘护理、减少哮喘恶化、管理城市内哮喘,以及一些潜在的新方法来利用现有药物改善哮喘控制。尽管在管理哮喘方面取得了许多重大进展,但我们现在必须找到改善预防哮喘恶化、改变疾病自然史以及减少哮喘护理中的健康差异的策略。也许个性化医学的新方向,包括系统生物学方法,以及改善医疗保健的可及性和沟通,将带来更好的方法来减轻哮喘的负担。这篇综述将讨论当前哮喘管理方法的优缺点、可能影响哮喘管理新方向的新研究,以及与哮喘和过敏性气道炎症机制相关的新见解,这些见解最终可能导致更好的哮喘控制。